NCT02093845 - Everolimus-eluting SYNERGY Stent Versus Biolimus-eluting Biomatrix NeoFlex Stent - SORT-OUT VIII | Biotech Hunter

Enrollment

2,800

Participants

Timeline

Start Date

February 10, 2014

Primary Completion Date

August 24, 2015

Study Completion Date

December 31, 2020

Conditions

Coronary Artery DiseaseIschemic Heart Disease

Interventions

DEVICE

Biomatrix NeoFlex coronary stent

Percutaneous coronary intervention involving use of stent

DEVICE

SYNERGY stent

Percutaneous coronary intervention involving use of stent

Trial Locations (3)

Odense University Hospital, Odense

Aarhus University Hospital, Skejby

Aarhus University Hospital Aalborg, Aalborg